ASTC: AI 评分 44/100 — AI 分析 (4月 2026)

Astrotech Corporation operates as a science and technology development and commercialization company. The company focuses on mass spectrometry technology for various applications, including explosives detection and cannabis analysis.

Key Facts: AI Score: 44/100 Sector: Industrials

公司概况

概要：

Astrotech Corporation, operating within the Industrials sector, focuses on science and technology development, particularly mass spectrometry. Its segments cater to explosives detection, cannabis analysis, and breath analysis, positioning it as a diversified technology commercialization company with a small market capitalization.

ASTC是做什么的？

Astrotech Corporation, originally founded in 1984 as SPACEHAB, Inc. and rebranded in 2009, is a science and technology development and commercialization company. Headquartered in Austin, Texas, the company operates through three primary segments: Astrotech Technologies, Inc. (ATI), 1st Detect Corporation, and AgLAB Inc. ATI focuses on owning and licensing the AMS Technology, a platform mass spectrometry technology. 1st Detect manufactures explosives and narcotics trace detectors, notably the TRACER 1000, aimed at replacing existing detection systems in airports, secured facilities, and borders. AgLAB develops mass spectrometry tools, including AgLAB-1000 for the hemp and cannabis market, and BreathTest-1000, a breath analysis tool designed to screen for volatile organic compound metabolites. Astrotech's business model centers on developing and commercializing innovative technologies across diverse sectors, leveraging its expertise in mass spectrometry to address specific market needs. Despite its innovative focus, the company faces challenges related to profitability and market penetration.

ASTC的投资论点是什么？

Astrotech Corporation presents a speculative investment thesis centered on its technology commercialization efforts, particularly in the explosives detection and cannabis analysis markets. The company's negative P/E ratio of -0.29 and a significant negative profit margin of -1163.9% indicate substantial financial challenges. However, potential growth catalysts include the broader adoption of TRACER 1000 in security applications and the expansion of AgLAB-1000 in the burgeoning cannabis industry. Investors should closely monitor the company's ability to improve its financial performance and successfully commercialize its technologies. The company's small market capitalization and high beta of 0.37 suggest significant volatility and risk.

ASTC在哪个行业运营？

Astrotech Corporation operates in the Aerospace & Defense industry, specifically within the technology development and commercialization niche. The industry is characterized by intense competition, rapid technological advancements, and stringent regulatory requirements. Astrotech's focus on mass spectrometry applications for explosives detection and cannabis analysis positions it in specialized segments of the broader market. The company competes with larger, more established players in the security and analytical instrumentation sectors. Market trends include increasing demand for advanced security technologies and growing interest in cannabis testing solutions.

Aerospace & Defense

Industrials

ASTC有哪些增长机遇？

Expansion of TRACER 1000 in Security Applications: The increasing need for enhanced security measures at airports, secured facilities, and borders presents a significant growth opportunity for Astrotech's 1st Detect segment. The global explosives detection market is projected to reach billions of dollars by 2028. Successful deployment and adoption of TRACER 1000 as a replacement for existing explosives trace detectors could drive substantial revenue growth. The timeline for realizing this opportunity depends on regulatory approvals and market acceptance.
Penetration of AgLAB-1000 in the Cannabis Market: The burgeoning cannabis industry requires accurate and reliable testing solutions for quality control and regulatory compliance. Astrotech's AgLAB-1000 mass spectrometer offers a potential solution for analyzing hemp and cannabis products. The cannabis testing market is expected to grow significantly in the coming years, providing a favorable environment for AgLAB's expansion. Success hinges on product validation and market penetration strategies.
Commercialization of BreathTest-1000 for Medical Applications: Astrotech's BreathTest-1000, designed to screen for volatile organic compound metabolites in a person's breath, has potential applications in medical diagnostics and health monitoring. The breath analysis market is expanding, driven by advancements in sensor technology and increasing demand for non-invasive diagnostic tools. Successful development and commercialization of BreathTest-1000 could open new revenue streams for Astrotech.
Licensing of AMS Technology: Astrotech Technologies, Inc. (ATI) owns and licenses the AMS Technology, a platform mass spectrometry technology. Expanding the licensing of this technology to other companies and research institutions could generate recurring revenue streams for Astrotech. The market for mass spectrometry technologies is broad, encompassing various applications in pharmaceuticals, environmental monitoring, and materials science. The timeline for realizing this opportunity depends on successful technology transfer and market demand.
Strategic Partnerships and Acquisitions: Astrotech could pursue strategic partnerships or acquisitions to expand its technology portfolio, market reach, and customer base. Collaborating with complementary technology providers or acquiring companies with established market positions could accelerate Astrotech's growth trajectory. The timeline for realizing this opportunity depends on identifying suitable partners or acquisition targets and successfully integrating them into Astrotech's operations.

Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
P/E ratio of -0.29 reflects current losses, suggesting the company's earnings are negative.
Profit margin of -1163.9% highlights substantial operational inefficiencies and challenges in achieving profitability.
Gross margin of 14.7% indicates a limited ability to control production costs.
Beta of 0.37 suggests lower volatility compared to the overall market.

ASTC提供哪些产品和服务？

Develops and commercializes science and technology solutions.
Operates through three segments: Astrotech Technologies, 1st Detect, and AgLAB.
Licenses AMS Technology, a platform mass spectrometry technology.
Manufactures explosives and narcotics trace detectors.
Provides TRACER 1000 for explosives detection at airports and secured facilities.
Develops AgLAB-1000 for use in the hemp and cannabis market.
Develops BreathTest-1000 for breath analysis.

ASTC如何赚钱？

Develops and commercializes technology products.
Generates revenue through product sales and licensing agreements.
Targets specific markets such as security, cannabis, and medical diagnostics.

Airports and secured facilities requiring explosives detection.
Hemp and cannabis testing laboratories.
Potential customers for breath analysis tools in medical and health monitoring.

Proprietary AMS Technology platform.
Specialized expertise in mass spectrometry applications.
Established presence in niche markets such as explosives detection.

什么因素可能推动ASTC股价上涨？

Upcoming: Potential regulatory approvals for TRACER 1000 in international markets.
Ongoing: Expansion of AgLAB-1000 sales in the cannabis industry.
Ongoing: Development and commercialization of BreathTest-1000 for medical applications.

ASTC的主要风险是什么？

Potential: Intense competition from larger companies in the security and analytical instrumentation markets.
Potential: Regulatory hurdles and compliance requirements for explosives detection and cannabis testing.
Ongoing: Negative profitability and high operating losses.
Potential: Dependence on successful commercialization of new products.

ASTC的核心优势是什么？

Proprietary AMS Technology platform
Specialized expertise in mass spectrometry
Established presence in niche markets
Diverse product portfolio across multiple segments

ASTC的劣势是什么？

Negative profitability and high operating losses
Small market capitalization and limited financial resources
Dependence on successful commercialization of new products
Limited brand recognition compared to larger competitors

ASTC有哪些机遇？

Expansion in the growing cannabis testing market
Increased demand for advanced security technologies
Potential applications of breath analysis tools in medical diagnostics
Strategic partnerships and acquisitions to expand market reach

ASTC面临哪些威胁？

Intense competition from larger, more established players
Regulatory hurdles and compliance requirements
Technological obsolescence and rapid advancements in the industry
Economic downturns and reduced government spending on security

ASTC的竞争对手是谁？

Antelope Enterprise Holdings Limited — Diversified holdings, not directly comparable. — (AEHL)
Bio-key International, Inc. — Focuses on biometric authentication solutions. — (BKYI)
China Natural Resources, Inc. — Resources company, not directly comparable. — (CHNR)
DFSC Global Corp. — Unknown business model. — (DFSC)
Galaxy Next Generation, Inc. — Focuses on interactive classroom technology. — (GLXG)

Key Metrics

MoonshotScore: 44/100

Company Profile

CEO: Thomas Boone Pickens
Headquarters: Austin, US
Employees: 30
Founded: 1995

AI Insight

AI analysis pending for ASTC

常见问题

What does Astrotech Corporation do?

Astrotech Corporation operates as a science and technology development and commercialization company, focusing on mass spectrometry technology. It has three segments: Astrotech Technologies, which licenses AMS Technology; 1st Detect, which manufactures explosives and narcotics trace detectors like the TRACER 1000; and AgLAB, which develops mass spectrometers for the cannabis market, such as the AgLAB-1000, and breath analysis tools like BreathTest-1000. The company aims to commercialize innovative technologies across diverse sectors.

What do analysts say about ASTC stock?

AI analysis is currently pending for ASTC, so there is no available analyst consensus, valuation metrics, or growth considerations. Investors should conduct their own due diligence and consult with financial professionals before making any investment decisions. The company's financial performance and market position should be carefully evaluated based on available data and industry trends.

What are the main risks for ASTC?

Astrotech Corporation faces several key risks, including intense competition from larger companies in the security and analytical instrumentation markets. The company's negative profitability and high operating losses pose a significant challenge. Regulatory hurdles and compliance requirements for explosives detection and cannabis testing add to the risk profile. The company's dependence on successful commercialization of new products also presents a risk, as market acceptance and adoption are not guaranteed.